Survival in patients with advanced pancreatic cancer is particularly poor, and improvements in diagnosis and treatment are urgently needed. Identification of new biomarkers and targets in pancreatic cancer could enable prediction of treatment response. In this Review, Costello and colleagues describe predictive pancreatic cancer biomarkers as well as novel treatment approaches and future treatment targets.
- Eithne Costello
- William Greenhalf
- John P. Neoptolemos
